Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
the latest technology. We encourage applicants with a strong background in biophysics, mechanical or biomedical engineering, material science, biochemistry, or a related field to apply. Candidates should have
-
, identification, narrative quality, and emotional impact. These are interrelated, yet their specific impact on memory work remains underexplored. Selected References Challenor, J. & Ma, M. (2019). A review of
-
innovations, and connect their work to the broader community. This unique program is open to all current PhD students at Tandon School of Engineering who will defend their dissertations by September 1, 2026
-
1 Oct 2025 Job Information Organisation/Company Imperial College London Department Electrical and Electonic Engineering Research Field Engineering » Electrical engineering Researcher Profile First
-
. New precision medicine avenues to the prevention of Alzheimer's disease from insights into the structure and function of gamma-secretases. EMBO J 43, 887-903 (2024). Rue, L. et al. Novel Human/Non-Human
-
. Matocq (UNR), M. Holding (Univ. Michigan), K. Everson (Oregon State Univ.), D. Schield (Univ. Virginia), and J. Dumbacher and J. Henderson (Calif. Acad. Sci.). The position has the potential to be renewed
-
22 Oct 2025 Job Information Organisation/Company Nantes Université Research Field Engineering » Chemical engineering Researcher Profile Recognised Researcher (R2) Positions Postdoc Positions Country
-
of society. INL aims to be a recognised leading global nanotechnology innovation hub. Where to apply Website https://app.jobvite.com/j?aj=oJHOyfww&s=Euraxess Requirements Research FieldPharmacological
-
27 Oct 2025 Job Information Organisation/Company International Iberian Nanotechnology Laboratory (INL) Research Field Engineering » Biomedical engineering Researcher Profile First Stage Researcher
-
disease from insights into the structure and function of gamma-secretases. EMBO J 43, 887-903 (2024). Rue, L. et al. Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies